Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis

被引：0
作者：
Cigliola, Antonio [1 ]
Mercinelli, Chiara [1 ]
Patane, Damiano [1 ]
Raggi, Daniele [1 ]
Necchi, Andrea [1 ,2 ]
机构：
[1] IRCCS Osped San Raffaele, Dept Med Oncol, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
EUROPEAN UROLOGY | 2023年 / 84卷 / 06期
关键词：
CISPLATIN; NIVOLUMAB;
D O I：
10.1016/j.eururo.2023.06.026
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：602 / 603
页数：2
相关论文
共 50 条
  • [31] Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy
    Masson-Lecomte, Alexandra
    Xylinas, Evanguelos
    Bouquot, Morgane
    Sibony, Mathilde
    Allory, Yves
    Comperat, Eva
    Zerbib, Marc
    de la Taille, Alexandre
    Roupret, Morgan
    WORLD JOURNAL OF UROLOGY, 2015, 33 (08) : 1087 - 1093
  • [32] Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis
    Andres Garcia-Perdomo, Herney
    Eduardo Montes-Cardona, Carlos
    Guacheta, Marcela
    Fernando Castillo, Diego
    Reis, Leonardo O.
    WORLD JOURNAL OF UROLOGY, 2018, 36 (12) : 1997 - 2008
  • [33] Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy
    Sikic, Danijel
    Weyerer, Veronika
    Geppert, Carol I.
    Bertz, Simone
    Lange, Fabienne
    Taubert, Helge
    Wach, Sven
    Schmitz-Draeger, Bernd J.
    Wullich, Bernd
    Hartmann, Arndt
    Eckstein, Markus
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (02) : 63.e19 - 63.e26
  • [34] Survival outcomes of patients diagnosed with muscle-invasive bladder cancer who showed a response after neoadjuvant chemotherapy and refused radical cystectomy, and patients who had radical cystectomy or received chemoradiotherapy
    Tunc, Sezai
    Urakci, Zuhat
    Ebinc, Senar
    Ileri, Serdar
    Kalkan, Ziya
    Oruc, Zeynep
    Kucukoner, Mehmet
    Kaplan, Muhammet Ali
    Isikdogan, Abdurrahman
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (05): : 331 - 338
  • [35] Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer In response to: Dirk Bohmer and Arne Grun. Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer
    Jiang, Di Maria
    Chung, Peter
    Kulkarni, Girish S.
    James, Nick D.
    Sridhar, Srikala S.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (03)
  • [36] Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium
    Gopalakrishnan, Dharmesh
    Elsayed, Ahmed S.
    Hussein, Ahmed A.
    Jing, Zhe
    Li, Qiang
    Wagner, Andrew A.
    Aboumohamed, Ahmed
    Roupret, Morgan
    Balbay, Derya
    Wijburg, Carl
    Stockle, Michael
    Dasgupta, Prokar
    Khan, Muhammad Shamim
    Wiklund, Peter
    Hosseini, Abolfazl
    Peabody, James
    Shigemura, Katsumi
    Trump, Donald
    Guru, Khurshid A.
    Chatta, Gurkamal
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (03) : 197 - 205
  • [37] Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience
    Boeri, Luca
    Soligo, Matteo
    Frank, Igor
    Boorjian, Stephen A.
    Thompson, R. Houston
    Tollefson, Matthew
    Tarrel, Robert
    Quevedo, Fernando J.
    Cheville, John C.
    Karnes, R. Jeffrey
    WORLD JOURNAL OF UROLOGY, 2019, 37 (11) : 2409 - 2418
  • [38] Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience
    Luca Boeri
    Matteo Soligo
    Igor Frank
    Stephen A. Boorjian
    R. Houston Thompson
    Matthew Tollefson
    Robert Tarrel
    Fernando J. Quevedo
    John C. Cheville
    R. Jeffrey Karnes
    World Journal of Urology, 2019, 37 : 2409 - 2418
  • [39] Survival of Patients with Muscle-Invasive Urothelial Cancer of the Bladder with Residual Disease at Time of Cystectomy: A Comparative Survival Analysis of Treatment Modalities in the National Cancer Database
    Pfail, John L.
    Audenet, Francois
    Martini, Alberto
    Tomer, Nir
    Paranjpe, Ishan
    Daza, Jorge
    Attalla, Kyrollis
    Waingankar, Nikhil
    Mehrazin, Reza
    Wiklund, Peter
    Galsky, Matthew D.
    Sfakianos, John P.
    BLADDER CANCER, 2020, 6 (03) : 265 - 276
  • [40] Three versus four cycles of neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysis
    Wang, Yulong
    Song, Yuxuan
    Qin, Caipeng
    Zhang, Chunlong
    Du, Yiqing
    Xu, Tao
    ANNALS OF MEDICINE, 2023, 55 (02)
12345